The current disclosure relates to high-affinity antibodies to EphA3 that have reduced immunogenicity when administered to a human to treat diseases and method of using such antibodies.
申请公布号
WO2011053465(A1)
申请公布日期
2011.05.05
申请号
WO2010US52725
申请日期
2010.10.14
申请人
KALOBIOS PHARMACEUTICALS, INC.;LUEHRSEN, KENNETH;MARTINEZ, DAVID;YI, CHRISTINA;BEBBINGTON, CHRISTOPHER R.;YARRANTON, GEOFFREY T.
发明人
LUEHRSEN, KENNETH;MARTINEZ, DAVID;YI, CHRISTINA;BEBBINGTON, CHRISTOPHER R.;YARRANTON, GEOFFREY T.
